Who are the other senior leaders and board members at Neurocept and how do they interact with Dr Cox?
Executive summary
Available sources do not list a company called “Neurocept” with a public senior leadership team or board; most results about “Neurocept” are consumer supplement reviews and do not name executives or describe interactions with a Dr. Cox (not found in current reporting) [1] [2] [3]. Reporting on several individuals named “Cox” (Paul Alan Cox and multiple physician Coxes) appears across different organizations, but no source connects any of them to Neurocept’s leadership or board [4] [5] [6].
1. No corporate leadership roster for “Neurocept” appears in supplied sources
Search results that mention Neurocept are product and review pieces about a brain-health supplement and do not provide an executive team, board list, or governance documents [1] [2] [3]. Those items focus on ingredients, consumer reviews and positioning in the supplement market rather than corporate governance or personnel. Available sources do not mention a senior leadership list for Neurocept or link a Dr. Cox to the company [1] [2] [3].
2. Multiple unrelated “Cox” figures appear across sources; none are tied to Neurocept
The supplied material contains profiles of several professionals surnamed Cox — Paul Alan Cox (ethnobotanist and researcher) and several physicians (Bridger Cox, Stephen Cox, Benjamin Cox, etc.) — but the sources treat them in different institutional contexts (academic labs, medical practices, nonprofits) and do not connect any of them to Neurocept’s board or management [4] [6] [7] [8]. For example, Paul Alan Cox is documented as director of Brain Chemistry Labs and founder of Seacology, with no mention in these sources of a role at Neurocept [4] [9] [5].
3. What the supplement-focused sources actually say about Neurocept
Two press-style pieces and an expert-opinion review present Neurocept as a brain-health supplement that received attention in 2025 for its ingredients and consumer interest; they emphasize product positioning and user reports rather than corporate structure [1] [2] [3]. Those articles explicitly frame Neurocept as a wellness product and repeatedly note that it is not intended to treat disease — but they do not identify executives, investors, or a board [1] [3].
4. Where the reporting does identify leaders named “Cox,” their roles are clear and separate
Paul Alan Cox is profiled as an ethnobotanist with long-standing nonprofit and research roles (Brain Chemistry Labs, Seacology) and a publication/award history; those sources describe his research work and advisory positions but do not place him on a supplement company board [4] [9] [5]. Clinical profiles of physicians named Cox show hospital affiliations and practice details (e.g., neurosurgeons and neurologists), again with no link to Neurocept’s governance [6] [10] [7].
5. Possible explanations for the gap — and what to check next
The most likely reasons the supplied reporting doesn’t show Neurocept’s senior leaders are: (a) Neurocept in these sources is presented primarily as a consumer product rather than a public company with disclosed governance, and (b) individuals named Cox referenced in other contexts are unrelated professionals. To resolve the question, seek primary corporate filings, a company “About/Leadership” page, press releases naming executives, or business-registry records — none of which are present in the current results (available sources do not mention those items) [1] [2].
6. Caveats, competing perspectives and hidden agendas in the sources
Supplement-review and press-release pieces have different incentives: review sites aim to evaluate a consumer product and may highlight benefits and consumer anecdotes, while presswire/newswire content can mirror marketing messages; both often omit corporate governance details [1] [2] [3]. Academic or nonprofit profiles of individuals named Cox emphasize research and public-interest work, not commercial supplement enterprises; conflating the two would be a category error not supported by the supplied material [4] [5].
7. Bottom line and recommended next steps
Based on the available reporting, there is no sourced list of Neurocept’s senior leaders or board members and no documented interaction between any “Dr. Cox” and Neurocept in these materials [1] [2] [3] [4]. For a definitive answer, request the company’s corporate/about page, press releases announcing leadership, state business filings, or independent business databases; those specific records are not included in the current sources (available sources do not mention them).